Literature DB >> 20113588

Neisseria meningitidis serogroup X sequence type 2888, Italy.

Cecilia Fazio, Stefania Starnino, Marina Dal Solda, Tonino Sofia, Arianna Neri, Paola Mastrantonio, Paola Stefanelli.   

Abstract

Entities:  

Mesh:

Year:  2010        PMID: 20113588      PMCID: PMC2958031          DOI: 10.3201/eid1602.091553

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


× No keyword cloud information.
To the Editor: Neisseria meningitidis serogroup X was first described in the 1960s and has been found to be responsible of rare cases of invasive meningococcal diseases, in particular, meningitis, in North America, Europe, Australia, Africa, and the People’s Republic of China (–). This serogroup has recently emerged in Africa as an increasing cause of meningitis; unfortunately, it is not covered by current vaccine programs. Serogroup X outbreaks have been reported in Niger, Ghana, and Kenya (–). In particular, in Niger during January–June 2006, N. meningitidis serogroup X represented 51% of confirmed cases of meningitis (). To investigate the population structure of serogroup X meningococci isolated during recent decades in Africa, Europe, and North America, Gagneux et al. () compared the molecular characteristics among them. That study highlighted a low genetic variability between African serogroup X strains, which contrasts with higher genetic variability among isolates from Europe and the United States (). We describe a case of invasive meningococcal disease caused by a serogroup X N. meningitidis strain isolated in Italy. The patient was a 55-year-old Italian woman with no immune deficiency. The onset of disease started quickly with high fever (39°C) on June 1, 2009. No contacts with persons coming from abroad were reported. This case was diagnosed on the basis of clinical signs and symptoms and results of laboratory confirmatory tests, including blood culture. The patient received ceftriaxone (2 g/day) for 7 days with a favorable outcome. The strain was susceptible to penicillin G, rifampin, ciprofloxacin, and ceftriaxone, as determined by Etest method (bioMérieux, Florence, Italy). The breakpoints were those recommended by the Clinical and Laboratory Standards Institute (). Serogroup was determined by serum agglutination, and serotype/subtype, NT:P1.15, 19 were determined by standard whole-cell ELISA with monoclonal antibodies (obtained from the National Institute for Biological Standards and Control, South Mimms, UK) (). PorA variable regions, FetA, and multilocus sequence typing analyses were performed according to standard procedures from the Neisseria Multi Locus Sequence Typing Web site (http://pubmlst.org/neisseria). The isolate from Italy had the pattern PorA VR1–19, VR2–15, and VR3–36; F5–5 and sequence type (ST)-2888. The same ST was already described in Greece in 2002 but in a noninvasive strain (http://pubmlst.org/neisseria). The pattern obtained by pulsed-field gel electrophoresis (), using the rare-cutting enzyme NheI, (data not shown), was identical to patterns found among meningococci X strains isolated in United Kingdom and belonging to ST-750, clonal group X-II (). In particular, ST-2888 resembles, except for gdh gene sequence, ST-2317, which was found among the X meningococci isolated in the United Kingdom in 2002 with phenotype X:4:P1.7 (http://pubmlst.org/neisseria). Our data document a rare case of invasive meningococcal meningitis in Italy, caused by N. meningitidis serogroup X ST-2888. Future surveillance data may be able to determine epidemiologic influences, likely emanating from nearby countries, on the spread of such a strain into Italy.
  7 in total

1.  Epidemiology and risk factors for serogroup X meningococcal meningitis during an outbreak in western Kenya, 2005-2006.

Authors:  David M Mutonga; Guillermo Pimentel; Judith Muindi; Charles Nzioka; Julius Mutiso; John D Klena; Myriam Morcos; Thomas Ogaro; Sadiki Materu; Christopher Tetteh; Nancy E Messonnier; Robert F Breiman; Daniel R Feikin
Journal:  Am J Trop Med Hyg       Date:  2009-04       Impact factor: 2.345

2.  Meningococcal meningitis: unprecedented incidence of serogroup X-related cases in 2006 in Niger.

Authors:  Pascal Boisier; Pierre Nicolas; Saacou Djibo; Muhamed-Kheir Taha; Isabelle Jeanne; Halima Boubacar Maïnassara; Bernard Tenebray; Kiari Kaka Kairo; Dario Giorgini; Suzanne Chanteau
Journal:  Clin Infect Dis       Date:  2007-01-25       Impact factor: 9.079

3.  A first meningococcal meningitis case caused by serogroup X Neisseria meningitidis strains in China.

Authors:  Chao Chen; Tie-gang Zhang; Jing-guo He; Jiang Wu; Li-juan Chen; Jun-feng Liu; Xing-huo Pang; Jie Yang; Zhu-jun Shao; Ying-chun Huang
Journal:  Chin Med J (Engl)       Date:  2008-04-05       Impact factor: 2.628

4.  Prospective study of a serogroup X Neisseria meningitidis outbreak in northern Ghana.

Authors:  Sébastien P Gagneux; Abraham Hodgson; Tom A Smith; Thierry Wirth; Ingrid Ehrhard; Giovanna Morelli; Blaise Genton; Fred N Binka; Mark Achtman; Gerd Pluschke
Journal:  J Infect Dis       Date:  2002-02-14       Impact factor: 5.226

5.  Clonal groupings in serogroup X Neisseria meningitidis.

Authors:  Sébastien Gagneux; Thierry Wirth; Abraham Hodgson; Ingrid Ehrhard; Giovanna Morelli; Paula Kriz; Blaise Genton; Tom Smith; Fred Binka; Gerd Pluschke; Mark Achtman
Journal:  Emerg Infect Dis       Date:  2002-05       Impact factor: 6.883

6.  Typing of sequential bacterial isolates by pulsed-field gel electrophoresis.

Authors:  A I Hartstein; P Chetchotisakd; C L Phelps; A M LeMonte
Journal:  Diagn Microbiol Infect Dis       Date:  1995-08       Impact factor: 2.803

7.  Infections by Neisseria meningitidis serogroup X in Spain.

Authors:  C M del Castillo; J A Vázquez; J Romero; A Pascual
Journal:  Clin Microbiol Infect       Date:  2003-09       Impact factor: 8.067

  7 in total
  5 in total

1.  Molecular and serological diversity of Neisseria meningitidis carrier strains isolated from Italian students aged 14 to 22 years.

Authors:  Roberto Gasparini; Maurizio Comanducci; Daniela Amicizia; Filippo Ansaldi; Paola Canepa; Andrea Orsi; Giancarlo Icardi; Emanuela Rizzitelli; Gabriella De Angelis; Stefania Bambini; Monica Moschioni; Sara Comandi; Isabella Simmini; Giueseppe Boccadifuoco; Brunella Brunelli; Marzia Monica Giuliani; Mariagrazia Pizza; Donatella Panatto
Journal:  J Clin Microbiol       Date:  2014-03-19       Impact factor: 5.948

2.  Phenotypic characterization of Neisseria meningitidis strains isolated from invasive meningococcal disease in Brazil from 2002 to 2017.

Authors:  Maria Cecília Gorla; Angela Pires Brandao; Juliana Maira Watanabe Pinhata; Camile de Moraes; Gabriela Pereira; Ana Paula Lemos
Journal:  Access Microbiol       Date:  2019-12-10

3.  Meningococci of Serogroup X Clonal Complex 181 in Refugee Camps, Italy.

Authors:  Paola Stefanelli; Arianna Neri; Paola Vacca; Damiano Picicco; Laura Daprai; Giulia Mainardi; Gian Maria Rossolini; Alessandro Bartoloni; Anna Anselmo; Andrea Ciammaruconi; Antonella Fortunato; Anna Maria Palozzi; Silvia Fillo; Marino Faccini; Sabrina Senatore; Florigio Lista; Cecilia Fazio
Journal:  Emerg Infect Dis       Date:  2017-05       Impact factor: 6.883

4.  Invasive Meningococcal X Disease during the COVID-19 Pandemic, Brazil.

Authors:  Lucila O Fukasawa; Bernadete L Liphaus; Maria Gisele Gonçalves; Fabio T Higa; Carlos H Camargo; Telma R M P Carvalhanas; Ana Paula S Lemos
Journal:  Emerg Infect Dis       Date:  2022-09       Impact factor: 16.126

5.  An efficient cell free enzyme-based total synthesis of a meningococcal vaccine candidate.

Authors:  Timm Fiebig; Maria Rosaria Romano; Davide Oldrini; Roberto Adamo; Marta Tontini; Barbara Brogioni; Laura Santini; Monika Berger; Paolo Costantino; Francesco Berti; Rita Gerardy-Schahn
Journal:  NPJ Vaccines       Date:  2016-11-15       Impact factor: 7.344

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.